Thymalin
Get a source-linked, educational explanation from this profile.
Complete Research Guide
Open each section for the available evidence. Gaps are stated rather than inferred.
Overview
Thymalin is listed as immune / bioregulator.
- •Immune restoration (research)
- •Longevity bioregulator protocols
Regulatory status: Approved in Russia/CIS; research-only elsewhere.
Structure & Properties
Compound: Thymalin; also known as Thymus extract peptide.
Pharmacologic class: Immune / Bioregulator.
Known delivery routes: Intramuscular, Subcutaneous.
Sequence, molecular weight, salt form, and excipient details are formulation-specific and are not listed unless verified by a manufacturer or laboratory COA.
How It Works
Thymic peptide complex that promotes T-lymphocyte differentiation and rebalances immune signaling in immunosenescence.
- •T-cell subset normalization in older adults
- •Reported reduction in infection frequency
Human Research
Evidence grade: Pre-clinical / Observational
Evidence is primarily preclinical or observational; human effectiveness and long-term safety are not established.
Laboratory Research
Russian clinical and gerontology literature
Preclinical findings describe biological plausibility, not proven benefit in people. Animal and laboratory doses do not translate directly to human use.
Processing & Interactions
Timing and exposure
No strict time-of-day requirement. Dose consistently at the same time daily and rotate injection sites. Follow the per-peptide dosing section above.
Potential interactions and combinations to avoid
- •Avoid stacking with peptides that share the same receptor or mechanism without clinical guidance.
- •Avoid combining with alcohol or immunosuppressants unless cleared by a clinician.
Absorption, half-life, metabolism, and clearance can vary by formulation and route. Use prescribing information when an approved product exists.
Safety & Precautions
Known or reported risks
- •Autoimmune flare potential
- •Injection-site reaction
- •Limited Western trial data
Contraindications
- •Autoimmune disease
- •Immunosuppressive therapy
- •Pregnancy
- •Autoimmune disease in active flare (immune activation may worsen symptoms)
- •Solid-organ or stem-cell transplant recipients on immunosuppression (rejection risk)
- •Concurrent biologic immunosuppressants or systemic corticosteroids without specialist input
- •Untreated acute infection requiring standard antimicrobial therapy
- •Any current or prior cancer diagnosis (apoptotic and telomerase pathways are tumor-relevant)
- •Impaired hepatic or renal clearance (senescent-cell debris burden)
- •Active wound healing or post-surgical recovery (senescent cells participate in repair)
- •Bleeding disorders or anticoagulant therapy without physician guidance (injection-site haematoma)
- •Active skin infection, cellulitis, or lipohypertrophy at intended injection sites
- •Inability to maintain sterile technique or safe sharps disposal
- •Not FDA-approved for human therapeutic use — no verified purity, sterility, or potency standards
- •Immunocompromised or transplant patients (unverified sterility and immunogenicity risk)
- •Concurrent participation in drug-tested sport (WADA prohibited or non-cleared substance)
- •Known hypersensitivity or prior reaction to this compound or any excipient/diluent
- •Pregnancy, attempting conception, or breastfeeding unless prescribed and monitored by a physician
- •Children and adolescents with open growth plates (unless under specialist endocrine care)
- •Active or recently treated malignancy without oncology clearance
- •Use without a confirmed diagnosis, baseline labs, and licensed clinical supervision
Unknown long-term toxicity should be assumed where controlled human data are limited. Seek urgent care for a severe or unexpected reaction.
Administration & Studied Formulations
Reference range: 5–10 mg/day
Frequency: Daily for 5–10 days per course
Cycling: Courses of 5–10 days, repeated 2–3× per year.
Intramuscular (IM)
Used for depot formulations, some GH secretagogues (localized delivery), and clinical protocols requiring faster systemic uptake.
23–25G × 1–1.5" needle. 1–3 mL syringe. Ventrogluteal, vastus lateralis, or deltoid. Insert 90°, aspirate (optional), inject slowly. Rotate sites weekly.
Subcutaneous (SubQ)
Default route for most research and therapeutic peptides — best absorption for reconstituted powder.
31G × 5/16" insulin syringe (U-100). 100 units = 1 mL. Pinch skin at abdomen (2" from navel), outer thigh, or love handle. Insert at 45–90°. Rotate sites daily to prevent lipohypertrophy. Alcohol-swab site, air-dry, inject slow, hold 5 sec.
Dosing information is educational context, not a personal recommendation. Approved products must follow their label and prescriber instructions.
Applications & Related Therapies
Potentially complementary measures
- •Most peptides pair safely with baseline nutrition, sleep, and resistance training.
Clinical use should account for diagnosis, approved alternatives, nutrition, activity, sleep, rehabilitation, current medicines, and appropriate monitoring.
Cases, Considerations & Ethics
Decision framework: establish the clinical goal, confirm evidence quality and legal status, screen contraindications and interactions, compare approved alternatives, define monitoring and stopping criteria, and use shared decision-making with a licensed clinician.
Case evidence: individual reports cannot establish safety or effectiveness and should not outweigh controlled trials.
Ethics: informed consent should distinguish established care from experimental use, disclose uncertainty and cost, avoid overstated claims, and never substitute research products for medically necessary care.
What is Thymalin?
In plain words
Thymalin is a mixture of small protein pieces extracted from animal thymus tissue, an organ involved in immune development. It may help certain immune cells mature and change how they send signals. Researchers study it for restoring immune function, including changes linked to aging. Strong clinical evidence is limited, and possible risks include reactions where it is injected and worsening of autoimmune conditions, in which the immune system attacks the body.
Technical definition
Thymalin is an animal thymus–derived peptide complex studied as an immune bioregulator, rather than a single peptide with a defined sequence. Its proposed activity involves promoting T-lymphocyte differentiation and modulating immune signaling during immunosenescence, or age-related immune decline; a specific molecular receptor has not been established. It is approved in Russia and some CIS countries but is not FDA-approved; evidence for immune restoration is primarily preclinical and observational.
Function
Dosing
Recommended Time of Day
Morning, fasted — short cycles.
See “Timing & Interactions” below for full fasted/fed circumstances, what to avoid combining, and what pairs well.
Administration & Technique
Injection & Application Sites
- Ventrogluteal — Palm on greater trochanter, index to ASIS — inject in the V. Safest IM site.
- Dorsogluteal (upper outer) — Upper outer quadrant of the buttock. Used for depot IM; alternate sides each cycle.
- Upper arm / deltoid — Back of the upper arm for SubQ; 2 in below the shoulder bone for IM.
- Anterior thigh (vastus lateralis) — Middle third of the outer front thigh. Preferred IM site for self-injection.
- Abdomen — 2 in (5 cm) away from the navel, either side. Fastest, most consistent SubQ absorption.
- Flank / love handle — Lateral fat pad above the hip. Good rotation site when the abdomen is tender.
- Outer thigh — Upper outer quadrant, a hand-width below the hip. SubQ pinch at 45°.
Diagram is a general illustration, not a medical instruction. Rotate sites every injection, keep 1 in (2.5 cm) between recent sites, and avoid scars, moles, bruises and the navel area.
Cycling
Courses of 5–10 days, repeated 2–3× per year.
Timing & Interactions
- ·Avoid stacking with peptides that share the same receptor or mechanism without clinical guidance.
- ·Avoid combining with alcohol or immunosuppressants unless cleared by a clinician.
- ·Most peptides pair safely with baseline nutrition, sleep, and resistance training.
Storage & Reconstitution
Reconstitution Calculator
1 mL = 100 units on a standard U-100 insulin syringe. Draw to the nearest 0.5 unit and confirm dosing with a clinician before injection.
Your Notes
Sign in to save personal notes on Thymalin and sync them to Vial Lab.
Benefits
- ·T-cell subset normalization in older adults
- ·Reported reduction in infection frequency
Risks
- ·Autoimmune flare potential
- ·Injection-site reaction
- ·Limited Western trial data
Contraindications
- ·Autoimmune disease
- ·Immunosuppressive therapy
- ·Pregnancy
- ·Autoimmune disease in active flare (immune activation may worsen symptoms)
- ·Solid-organ or stem-cell transplant recipients on immunosuppression (rejection risk)
- ·Concurrent biologic immunosuppressants or systemic corticosteroids without specialist input
- ·Untreated acute infection requiring standard antimicrobial therapy
- ·Any current or prior cancer diagnosis (apoptotic and telomerase pathways are tumor-relevant)
- ·Impaired hepatic or renal clearance (senescent-cell debris burden)
- ·Active wound healing or post-surgical recovery (senescent cells participate in repair)
- ·Bleeding disorders or anticoagulant therapy without physician guidance (injection-site haematoma)
- ·Active skin infection, cellulitis, or lipohypertrophy at intended injection sites
- ·Inability to maintain sterile technique or safe sharps disposal
- ·Not FDA-approved for human therapeutic use — no verified purity, sterility, or potency standards
- ·Immunocompromised or transplant patients (unverified sterility and immunogenicity risk)
- ·Concurrent participation in drug-tested sport (WADA prohibited or non-cleared substance)
- ·Known hypersensitivity or prior reaction to this compound or any excipient/diluent
- ·Pregnancy, attempting conception, or breastfeeding unless prescribed and monitored by a physician
- ·Children and adolescents with open growth plates (unless under specialist endocrine care)
- ·Active or recently treated malignancy without oncology clearance
- ·Use without a confirmed diagnosis, baseline labs, and licensed clinical supervision
Regulatory
Approved in Russia/CIS; research-only elsewhere
Veterinary Use (Pets)
No established veterinary protocol for Thymalin. Consult a licensed veterinarian before considering off-label use in any species.
Full veterinary reference →Functional Groups
Cited Works
Tap any study to open the published work.